Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate bill would delay imaging cuts

This article was originally published in The Gray Sheet

Executive Summary

Legislation introduced in the Senate Aug. 3 would temporarily suspend Medicare spending reductions for imaging services. The "Access to Medicare Imaging Act" (S 3795), introduced by Sens. Gordon Smith (R-Ore.) and Jay Rockefeller (D-W.Va.), would place a two-year hold on cuts mandated by the Deficit Reduction Act. The moratorium would delay payment reductions until Jan. 1, 2009, allowing time for the Government Accountability Office to analyze the impact of DRA cuts on patient access. S 3795 has seven cosponsors and has been referred to the Senate Finance Committee. Companion legislation in the House, introduced by Rep. Joe Pitts (R-Pa.), has been referred to the House Energy & Commerce Committee/Health Subcommittee (1"The Gray Sheet" July 3, 2006, p. 11)...

You may also be interested in...



Report Criticizes Imaging Payment Cuts To Physician Offices

Imaging stakeholders are pushing a new report that finds Medicare imaging service payments to physician office and hospital outpatient settings were already on equal aggregate footing before Congress stepped in with big cuts to the former setting earlier this year

House Bill Would Delay Cuts For Out-Of-Hospital Imaging Until 2009

Medicare spending cuts for imaging services, scheduled to take effect in January, would be put on hold under a bill introduced in the House June 28

Biogen Value-Based Contract Links Patient-Reported Outcomes To MS Drug Reimbursement

Biogen value-based contract with UPMC Health Plan ties payments to patient-reported outcomes for Tecfidera and Avonex. The company may seek something similar for Vumerity.

UsernamePublicRestriction

Register

MT023859

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel